{"id":"W3202433444","doi":"10.1016/j.annonc.2021.08.1121","title":"608P Apalutamide (APA) efficacy and safety in Asian patients with metastatic castration-sensitive prostate cancer (mCSPC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"EMD Serono; Genentech; Astellas Pharma; Eisai; Flatiron Health; Endocyte; Sanofi; Exelixis; Genomic Health; Janssen Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; American Association for Cancer Research; AstraZeneca; Ipsen; Constellation Pharmaceuticals","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Androgen deprivation therapy; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002860721,0.0002026346,0.0004509653,0.0001886774,0.0001605057,0.0003754851,0.000197526,0.0001496093,0.001487304],"category_scores_gemma":[0.000365639,0.0001018933,0.0003671147,0.0003651717,0.0002099141,0.0002820222,0.000161873,0.0005482532,0.000308576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000336695,"about_ca_system_score_gemma":0.000499333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002029939,"about_ca_topic_score_gemma":0.004013166,"domain_scores_codex":[0.9998866,0.0000348894,0.00001140009,0.00001467619,0.00002297632,0.00002935159],"domain_scores_gemma":[0.9998139,0.00002832116,0.00005173059,0.00001514075,0.00002482077,0.00006616172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1207956,0.006668866,0.3385638,0.000956415,0.002471413,0.001630252,0.0009436628,0.002145192,0.08786508,0.0006475341,0.004131289,0.433181],"study_design_scores_gemma":[0.01608311,0.1342993,0.8041921,0.0001317362,0.003094944,0.005217399,0.001055592,0.004899008,0.01949868,0.0007482073,0.01069122,0.00008876339],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975613,0.001025052,0.00005892581,0.00009400248,0.00001364711,0.00001738075,0.0001116044,0.00001248826,0.001105561],"genre_scores_gemma":[0.9989181,0.0004596709,0.0000719193,0.00006980584,0.0000134092,0.000009045473,0.0001303473,0.000003199437,0.000324537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002029939,"threshold_uncertainty_score":0.004975557,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0543074712341284,"score_gpt":0.3914125880459866,"score_spread":0.3371051168118582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}